Mandate

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.

On 31 March 2025, EQT X and First Kraft AB, acting through Omega II, announced a public offer to the shareholders of Fortnox to tender all shares in Fortnox to Omega II, valuing Fortnox at approximately SEK 55 billion. The shares in Fortnox are listed on Nasdaq Stockholm (Large Cap). The board of directors of Fortnox unanimously recommended that Fortnox's shareholders accept the offer.

Investor’s total investment in the public offer for Fortnox is expected to amount to approximately SEK 4.5 billion upon completion of the public offer, out of which approximately SEK 2.6 billion was invested during the second quarter of 2025.

Vinge's team primarily consisted of Jonas Johansson, Linus Adolfsson, Alexander Rüdén (M&A), Erik Sjöman, Sofie Bjärtun (Capital Markets), Viveka Classon and Olivia Carlsten (Financial Regulatory).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025